177 related articles for article (PubMed ID: 7252652)
1. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
Weinberger M; Hendeles L; Wong L
J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
[TBL] [Abstract][Full Text] [Related]
2. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
Hendeles L; Iafrate RP; Weinberger M
Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
[TBL] [Abstract][Full Text] [Related]
3. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
Weinberger MM
Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
[TBL] [Abstract][Full Text] [Related]
4. The relation of product formulation to absorption of oral theophylline.
Weinberger M; Hendeles L; Bighley L
N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
[TBL] [Abstract][Full Text] [Related]
5. Theophylline product and dosing interval selection for chronic asthma.
Hendeles L; Weinberger M
J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):285-91. PubMed ID: 4019956
[TBL] [Abstract][Full Text] [Related]
6. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
9. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
Pedersen S; Steffensen G
J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
[TBL] [Abstract][Full Text] [Related]
11. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
Haltom JR; Szefler SJ
J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
[TBL] [Abstract][Full Text] [Related]
12. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
Welch MJ; Kemp JP; Orgel HA; Meltzer EO
J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
[TBL] [Abstract][Full Text] [Related]
13. Update on the pharmacodynamics and pharmacokinetics of theophylline.
Hendeles L; Massanari M; Weinberger M
Chest; 1985 Aug; 88(2 Suppl):103S-111S. PubMed ID: 3893922
[TBL] [Abstract][Full Text] [Related]
14. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
15. Selection of a slow-release theophylline product.
Hendeles L; Weinberger M
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):743-51. PubMed ID: 3534055
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release theophylline for treatment of asthma in preschool children.
Simons FE; Luciuk GH; Simons KJ
Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
[TBL] [Abstract][Full Text] [Related]
17. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
Milavetz G; Vaughan LM; Weinberger MM; Harris JB; Mullenix TA
J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
Weinberger M
Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new sustained-release theophylline tablet for children.
Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
[TBL] [Abstract][Full Text] [Related]
20. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
Tinkelman DG; Lutz CN; Miller E; Cole WQ
Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
